FIRM FIXED PRICE

DMS PHARMACEUTICAL GROUP INC - 4570034326!ENTYVIO 300 MG VIALS

PIID: SPE2DR26FFBL0
Signed Date: Nov 13, 2025Effective Date: Nov 13, 2025End Date: Closed on Nov 14, 2025
Award $
$146K
Vendor
DMS PHARMACEUTICAL GROUP INC
NAICS
424210
Signed Date
Nov 13, 2025

Key Details

Dollars Obligated
$146,420.4
Base & All Options
$146,420.4
Awarding Agency
Department of Defense
Awarding Sub-Agency
Defense Logistics Agency
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
PARK RIDGE, IL, 600682302, CD-IL-09

Description

4570034326!ENTYVIO 300 MG VIALS

Context & Analysis

On Nov 13, 2025, Department of Defense obligated $146,420.4 to DMS PHARMACEUTICAL GROUP INC for 4570034326!entyvio 300 mg vials. The award is classified under NAICS 424210 — DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in PARK RIDGE, IL.

Contractor Information

UEI: PX72BSBQTKJ3
CAGE Code: 1UNB0
Location: PARK RIDGE, IL
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related